Company news

HLS Therapeutics, Inc. news in 2022

HLS Therapeutics, Inc.'s news releases, calls and decks from 2022, newest first.

View company

HLS Therapeutics Announces Board Appointment

November 29, 2022

HLS Therapeutics to Present at the Stifel Healthcare Conference

November 14, 2022

HLS Therapeutics Announces Q3 Fiscal 2022 Financial Results and Renewal of Normal Course Issuer Bid

November 10, 2022

HLS Therapeutics Highlights Key Data on the Late Breaking RESPECT-EPA Study Presented at the American Heart Association

November 7, 2022

HLS Therapeutics to Host Q3 Fiscal 2022 Financial Results Conference Call

October 27, 2022

HLS Therapeutics to Participate in Virtual Non-Deal Roadshow on September 22, 2022

September 15, 2022

HLS Therapeutics Announces Q2 Fiscal 2022 Financial Results

August 11, 2022

HLS announces that Vascepa® is now reimbursed by the Saskatchewan Drug Plan

August 2, 2022

HLS Therapeutics to Host Q2 Fiscal 2022 Financial Results Conference Call

July 28, 2022

HLS Announces that Vascepa® is now reimbursed by Ontario's Provincial Drug Plan

July 25, 2022

HLS Therapeutics Obtains Public Reimbursement for Vascepa® in New Brunswick and with other Public Payors

June 22, 2022

HLS Therapeutics to Participate in Virtual Non-Deal Roadshow on June 22, 2022

June 15, 2022

HLS Therapeutics to Present at the 2022 Jefferies Healthcare Conference

June 1, 2022

HLS Therapeutics Executive Chairman and Co-Founder Bill Wells to Retire

May 24, 2022

HLS Therapeutics Obtains Public Reimbursement for Vascepa® in Quebec

May 24, 2022

HLS Therapeutics Announces Q1 Fiscal 2022 Financial Results

May 5, 2022

HLS Therapeutics to Host Q1 Fiscal 2022 Financial Results Conference Call

April 28, 2022

HLS Therapeutics completes negotiations with pCPA for Vascepa®

April 26, 2022

HLS Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference

April 25, 2022

HLS Therapeutics Announces Q4 and Fiscal 2021 Financial Results

March 17, 2022

HLS Therapeutics to Host Q4 & Fiscal 2021 Financial Results Conference Call

March 14, 2022

HLS Therapeutics to Present at the Sidoti Investor Conference

January 12, 2022

Decks in 2022